Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Special MTA: None
ATGGAGGTCACGAACCTTATTGAAAAATGTACCAAGCACTCCAAAGATTTCGCCACTGAG
GTAAAAAAACTATGGAACGATGAGTTGAGTTCTGAATCAGGTCTCTCAAGAAAAACAAGA
AATGTAATTCGTAATATTCTTCGTGATATCACTAAGTCATTAACTACAGATAAGAAATCA
AAGTGTTTCCGTATACTAGAACGTTCGACGATTAACGGAGAGCAGATTAAAGATGTATAT
AAAACTATTTTTAATAATGGTGTTGATGTGGAGTCTAGAATCAACACTACAGGAAAGTAT
GTTCTATTTACAGTTATGACTTATGTTGCTGCTGAACTACGACTCATTAAGTCAGACGAG
ATATTCGCTCTTCTATCAAGATTTTTTAACATGATATGTGATATTCATAGAAAATACGGA
TGTGGTAATATGTTTGTTGGTATTCCCGCTGCTCTAATTATTCTGTTGGAAATTGATCAC
ATCAATAAACTGTTTAGCGTGTTTAGTACAAGATATGATGCTAAGGCATATCTATATACT
GAATATTTCCTCTTCCTTAACATTAATCATTATCTACTTAGTGGTTCAGATTTATTTATC
AACGTAGCATATGGTGCTGTATCTTTTTCGTCACCCATTAGTGTTCCAGATTATATCATG
GAAGCACTGACATTTAAGGCATGTGATCATATTATGAAATCTGGAGATCTAAAATATACA
TATGCGTTTACTAAAAAGGTTAAGGATCTGTTTAATACTAAATCTGATTCTATTTATCAA
TACGTTAGACTTCATGAAATGTCATATGATGGTGTTTCAGAAGATACGGATGATGACGAT
GAGGTATTCGCTATCCTTAACTTGAGTATTGATTCCAGCGTTGATAGATACAGAAACAGA
GTTCTTCTACTAACTCCCGAAGTCGCGTCTCTTAGAAAAGAATATTCAGACGTAGAACCC
GATTATAAATACTTGATGGATGAGGAAGTGCCCGCGTACGACAAGCATTTGCCTAAGCCT
ATTACTAACACTGGTATTGAAGAACCACACGCTACTGGAGGAGATGAGGACCAACCAATT
AAGGTTGTCCATCCCCCTAATAATGATAAAGATGATGCTATCAAGCCATACAATCCATTA
GAAGATCCTAATTATGTTCCCACAATTACAAGAACGGCTATAGGAATCGCTGATTACCAA
CTAGTTATTAATAAACTAATTGAATGGTTAGATAAATGCGAGGAAGAATGCGGAAATAGT
GGAGAGTTTAAAACAGAGTTGGAAGAAGCCAAGAGAAAACTCACCGAATTGAATGCAGAA
CTTAGTGATAAACTCAGTAAGATTAGGACTTTGGAAAGGGATTCTGTTTATAAAACCGAA
AGAATCGACCGACTTACAAAAGAGATCAAAGAACACAGGGATATTCAAAATGGGACAGAT
GATGGTTCAGATTTATTAGAAATTGATAAGAAGACTATCCGAGAATTGAGAGAATCGCTT
GATAGGGAACGAGAAATGCGTTCAGAACTAGAAAAGGAACTGGATACTATTAGGAATGGA
AAAGTAGATGGATCTTGTCAACGAGAACTTGAACTCAGTCGTATGTGGCTAAAACAACGC
GATGACGATCTCCGAGCTGAAATCGATAAACGTCGTAATGTCGAATGGGAACTGTCCAGA
CTTCGTAGGGATATCAAGGAATGCGACAAATACAAGGAGGATCTTGATAAGGCCAAGACA
ACTATTAGTAACTACGTAAGCAAAATCAGTACTCTAGAATCAGAAATTGCTAAATATCAA
CAAGATAGGGACACGCTTTCTGTAGTACGCAGAGAACTTGAGGAAGAACGACGACGCGTT
AGAGATCTCGAATCTAGACTCGATGAATGTACACGCAACCAGGAAGACACGCAAGAAGTT
GATGCACTGCGTTCGCGTATTAGAGAACTAGAGAATAAGTTGACCGACTGCATCGAGAGC
GGAGGAGGAAATCTTACAGAGATTAGCAGACTCCAATCTAAAATCTCAGATCTTGAAAGA
CAACTGAGTGAATGCCGTGAAAATGCTACAGAGATTAGCAGACTCCAATCTAGAATATCA
GATCTTGAAAGACAGTTGAACGACTGTAGACGTAATAATGAAACCAATGCCGAAACAGAG
AGAGATGCGACGTCT
MEVTNLIEKCTKHSKDFATEVKKLWNDELSSESGLSRKTRNVIRNILRDITKSLTTDKKS KCFRILERSTINGEQIKDVYKTIFNNGVDVESRINTTGKYVLFTVMTYVAAELRLIKSDE IFALLSRFFNMICDIHRKYGCGNMFVGIPAALIILLEIDHINKLFSVFSTRYDAKAYLYT EYFLFLNINHYLLSGSDLFINVAYGAVSFSSPISVPDYIMEALTFKACDHIMKSGDLKYT YAFTKKVKDLFNTKSDSIYQYVRLHEMSYDGVSEDTDDDDEVFAILNLSIDSSVDRYRNR VLLLTPEVASLRKEYSDVEPDYKYLMDEEVPAYDKHLPKPITNTGIEEPHATGGDEDQPI KVVHPPNNDKDDAIKPYNPLEDPNYVPTITRTAIGIADYQLVINKLIEWLDKCEEECGNS GEFKTELEEAKRKLTELNAELSDKLSKIRTLERDSVYKTERIDRLTKEIKEHRDIQNGTD DGSDLLEIDKKTIRELRESLDREREMRSELEKELDTIRNGKVDGSCQRELELSRMWLKQR DDDLRAEIDKRRNVEWELSRLRRDIKECDKYKEDLDKAKTTISNYVSKISTLESEIAKYQ QDRDTLSVVRRELEEERRRVRDLESRLDECTRNQEDTQEVDALRSRIRELENKLTDCIES GGGNLTEISRLQSKISDLERQLSECRENATEISRLQSRISDLERQLNDCRRNNETNAETE RDATS
Coding Sequence Details
Recommended Growth Condition: